SSI/ISID Fellowships


ISID and the Swiss Society for Infectious Diseases (SSI) jointly sponsor the SSI/ISID Infectious Diseases Research Fellowship Program.

The purpose of this Fellowship Program is to support infectious disease physicians and scientists from under-resourced countries through multidisciplinary clinical and laboratory training at select biomedical institutions in Switzerland. The objectives of the Fellowship Program are:

  • to train promising young physicians and scientists from under-resourced countries for clinical and research positions in infectious diseases
  • to foster partnerships between Fellows and infectious disease leaders in Switzerland
  • to increase scientific research capacity in under-resourced/high disease burden countries

Opportunities for training and research in a variety of areas ranging from basic studies of the mechanism of disease to studies in public health, epidemiology, diagnostics, therapeutics or vaccine development, are available through this program.

The term of the Fellowship is for one year. The start date of the will be determined by arrangement between the host institution and the Fellow.

A financial stipend of up to 36,000 SF per year (approximately $35,500 USD) will be given to Fellows to cover travel costs and living expenses.  The program intends to award two fellowships every year.

IMPORTANT NOTICE:  Language skills of French or German are necessary according to the institution chosen (German for Basel, Bern, Zurich and St. Gallen; French for Geneva and Lausanne).  Please indicate in your application your speaking and writing proficiency of these languages and of English.

Training Sites

SSI/ISID Fellows will be placed at one of six collaborating research centers in Switzerland according to technical interests and skills. All infectious diseases programs at each institution offer experience in clinical infectious diseases, including HIV, and microbiology. The technical research interests at each site include:

  • Bern: Clinical infectious disease in adults and children (Bern University Hospital) and Diagnostic and Research Laboratory (Institute of Infectious Diseases University of Bern).
    Hospital infection control and prevention and antibiotic stewardship; Pedriatic infectious diseases; HIV medicine; HIV-Hepatitis co-infections; Sexually transmitted infections; Molecular pathogenesis of respiratory pathogens and upper airway microbiome; Epidemiology and resistance of pneumococcus; Fungal infections; Antibiotic resistance; Opportunistic infections in AIDS, transplant patients and neutropenia; Travel medicine and migration medicine; Intestinal infection and microbiome; Pathogenesis of streptococci.
    (Furrer H, Aebi C, Marschall J, Rauch A, Duppentaler A, Agyeman P, Zimmerli S, Sendi P, Cusini A, Staehelin C, Hauser C at Bern University Hospital; TŠuber M, Hapfelmeier S, Hilty M; Endimiani A, Hathaway L at Institute for Infectious Diseases, University of Bern)
    Department of Infectious Diseases, Bern University Hospital:
    Pedriatic Infectious Diseases, Bern University Hospital:
    Institute of Infectious Diseases University of Bern:
  • Geneva: Clinical infectious diseases in adults or children. Prevention and control of infections; Antibiotic stewardship. Clinical trials in HIV infection. Osteomyelitis and bone prosthetic infections. Genomics, molecular biology and pathogenicity of S. aureus.
    Infections in transplant patients. Emerging and respiratory viruses.
    (Hirschel B, Gervaix A, Kaiser L, Kelley W, Lew D, Pittet , Schrenzel J, Uckay I, Van Delden C ) Additional information is available at:
  • Lausanne: Antibiotic stewardship, Monitoring of antibiotic use, Outpatient antibiotic therapy,
    Complicated bone and joint infections, Surgical implant associated-infections, Septic surgery, Diagnostic microbiology (MALDI-TOF, automation, molecular diagnosis), Infections in immunocompromised hosts, Infections in critically-ill and ICU patients, Emerging infections, Innate immunity, Immunogenetics of infectious diseases and genetic epidemiology, Infections due to intracellular bacteria (Chlamydiae, Coxiella, ..), Invasive fungal infections, HIV medicine (pharmacogenetics, drug monitoring, hepatitis C, neuro VIH, ..), Molecular epidemiology of nosocomial infections, Pediatric infectious diseases, Sepsis, Transplant infectious diseases, Vaccination in immunocompromised patients, Travel medicine and vaccinology. (Investigators: Asner S, Bochud PY, Calandra T, Cavassini M, S de Valliere, Genton B, Greub G, Lamoth F, Manuel O, Meylan P, Roger T, Senn L, Zanetti G)
    Infectious diseases Service, CHUV, Lausanne, Switzerland:
  • Basel: Infectious diseases; Hospital hygiene and epidemiology. Full clinical service in all areas of infectious diseases and hospital hygiene and epidemiology; Pathophysiology and clinical research including health economy; HIV: pathogenesis and course of disease.
    (Battegay M, Widmer A, Khanna N, Tschudin Sutter S, Stoeckle M)
    Division of Infectious Diseases & Hospital Epidemiology:
  • Zurich: Clinical trials in HIV. Molecular biology of HIV, latent reservoirs, and anti-HIV immune response. HIV epidemiology. Intestinal infections. Zoonotic infections. Hospital epidemiology. (Weber R, Ruef C, Guenthart H, Opravil M, Trkola A, Flepp M, Speck R, Ledergerber B)
    Department of Infectious Diseases and Hospital Epidemiology:
  • St. Gallen: Sexual transmission of HIV
    (Vernazza P).
    Additional information is available at:



The program is open to applicants who are citizens or permanent residents of under-resourced countries or Eastern Europe.  Applicants should have a M.D. or a Ph.D in a relevant field and should hold a position at a medical, research, or public health institution.  An endorsement by the home institution is required for participation in the program.


Applications should be made through our on-line submisson system.

Applications will be reviewed by a joint SSI and ISID committee. Selection will be based on the applicant’s academic potential, career plans, previous clinical/research experience, letters of reference, and relevance of training to home institution and home country. Personal interviews will be arranged with selected applicants as the final step in the application process.

The annual application deadline for Fellowship applications is 1 April.

Questions or requests additional information should be directed to:



Database Details

Current Research
No Profile listed
Thematic Focus
Life Sciences and Health


Applicant’s Country
other, Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Congo, Djibouti, DR Congo, Egypt, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Ivory Coast, Kenya, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Mauritius, Morocco, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Swaziland, Tanzania, Togo, Tunesia, Uganda, Zambia, Zimbabwe

Allowed Usage
Research, Mobility

Applicant’s Position
PostDoc, Researcher, Consortium

Cycle Type
Repeated annually

Partner Required

1. April 2017
Last Modification
15. April 2020